+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Combined psychopharmacological treatment among child and adolescent inpatients in Finland



Combined psychopharmacological treatment among child and adolescent inpatients in Finland



European Child and Adolescent Psychiatry 13(3): 179-184



The aim of this study is to report the prevalence and factors associated with combined pharmacotherapy among child and adolescent psychiatric inpatients in Finland. The target group was all child and adolescent psychiatric inpatients at the beginning of the year 2000. Information about medication use was obtained for 475 patients. The prevalence of combined pharmacotherapy was 16%. Of those taking pharmacotherapy, 36% had combined treatment. The most common combinations were neuroleptics and SSRIs. Most of the patients with combined pharmacotherapy had depressive or psychotic disorder. Among those with medication, older age (13-18 years), psychotic disorder, bipolar disorder, low functioning level (CGAS > 40) and involuntary treatment were associated with combined treatment. Illness severity and treatment resistance were associated with combined pharmacotherapy. Further studies on indications, safety and efficacy of combined pharmacotherapy are warranted.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048580921

Download citation: RISBibTeXText

PMID: 15254846

DOI: 10.1007/s00787-004-0373-3


Related references

Psychopharmacological treatment of child and adolescent psychiatric inpatients in Finland. Journal of Child and Adolescent Psychopharmacology 12(2): 147-155, 2002

Suicidal ideation and suicide attempts among child and adolescent psychiatric inpatients in Finland. Journal of Affective Disorders 76(1-3): 211-221, 2003

Changes in the clinical features of child and adolescent psychiatric inpatients: a nationwide time-trend study from Finland. Nordic Journal of Psychiatry 70(6): 436-441, 2016

The involuntary treatment of adolescent psychiatric inpatients--a nation-wide survey from Finland. Journal of Adolescence 31(3): 407-419, 2008

Psychopharmacological treatment options for global child and adolescent mental health: the WHO essential medicines lists. Journal of the American Academy of Child and Adolescent Psychiatry 47(10): 1105-1113, 2008

A comparative overview of treatment research methodology: adult vs. child and adolescent, psychopharmacological vs. psychosocial treatments. Psychopharmacology Bulletin 29(1): 5, 1993

Treatment utilisation and trauma characteristics of child and adolescent inpatients with posttraumatic stress disorder. Curationis 25(4): 67-72, 2002

Arctic co-operation in child and adolescent psychiatry. Proceedings from the VI Congress on Circumpolar Child and Adolescent Psychiatry. August 27-30, 1991, Kajaani, Finland. Arctic Medical Research 53(Suppl. 1): 1-71, 1994

Psychopharmacological preferences of Polish child and adolescent psychiatrists. European Child and Adolescent Psychiatry 8(4): 320-324, 1999

Off-Label Prescription of Psychopharmacological Drugs in Child and Adolescent Psychiatry. Journal of Clinical Psychopharmacology 36(5): 500-507, 2016

Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatrica Scandinavica. Supplementum: 1-22, 2003

Diagnostic and psychopharmacological treatment characteristics of 536 inpatients with posttraumatic stress disorder. Journal of Nervous and Mental Disease 177(3): 154-159, 1989

Association of traumatic brain injury with criminality in adolescent psychiatric inpatients from Northern Finland. Psychiatry Research 200(2-3): 767-772, 2012

From Psychopharmacological Evidence to Clinical Practice: Unmet Needs in Child & Adolescent Psychiatry - Reflections on Kölch & Plener. Pharmacopsychiatry 49(6): 227-228, 2016